INS and obesity disorder: In fact, their agonists may interact with components of multiple pathways in macrophages to modulate signaling crosstalk with metabolic tissues, coordinating a precise and appropriate cellular response in order to improve the insulin signaling and other obesity-related metabolic disorders.